Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol

J Arthroplasty. 2012 Feb;27(2):293-8. doi: 10.1016/j.arth.2011.04.044. Epub 2011 Jul 12.

Abstract

Fungal periprosthetic joint infections are a rare entity in orthopedic surgery, and there exist no guidelines according to which these infections can be successfully managed. Between 2004 and 2009, 7 patients with fungal periprosthetic joint infections (4 total hip arthroplasties and 3 total knee arthroplasties) have been treated with a 2-stage protocol and implantation of antibiotic-loaded cement spacers. Most of the infection was caused by Candida species. Systemic antifungal agents were administered for 6 weeks in 6 cases and 6 months in 1 case. The mean spacer implantation time was 12 weeks. At a mean follow-up of 28 months (5-70 months), no persistence of infection or reinfection could be observed. A 2-stage treatment protocol with implantation of an antibiotic-loaded cement spacer is an efficient option in the treatment of fungal periprosthetic infections.

MeSH terms

  • Aged
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Arthroplasty, Replacement, Hip / instrumentation
  • Arthroplasty, Replacement, Knee / instrumentation
  • Bone Cements*
  • Candida / isolation & purification
  • Candidiasis / therapy
  • Combined Modality Therapy
  • Debridement / methods
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Hip Joint / drug effects
  • Hip Joint / microbiology
  • Hip Joint / surgery
  • Hip Prosthesis / microbiology*
  • Humans
  • Knee Joint / drug effects
  • Knee Joint / microbiology
  • Knee Joint / surgery
  • Knee Prosthesis / microbiology*
  • Male
  • Middle Aged
  • Mycoses / therapy*
  • Prosthesis-Related Infections / therapy*
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Bone Cements